Clinical Trial Update: Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 trial evaluating sequencing of sipuleucel-T immunotherapy and androgen deprivation therapy in men with non-metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Prostatic Neoplasm, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30